14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Tuesday, 7th May 2024 CSLLY stock ended at $92.36. This is 0.687% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 2.57% from a day low at $91.79 to a day high of $94.15.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical CSL Ltd. prices

Date Open High Low Close Volume
May 07, 2024 $91.79 $94.15 $91.79 $92.36 48 027
May 06, 2024 $90.87 $91.84 $90.00 $91.73 25 205
May 03, 2024 $91.47 $91.91 $91.16 $91.19 32 227
May 02, 2024 $89.93 $91.17 $89.53 $91.05 23 848
May 01, 2024 $90.75 $90.75 $88.70 $89.14 50 646
Apr 30, 2024 $90.10 $90.14 $89.38 $89.60 185 776
Apr 29, 2024 $89.06 $91.75 $89.06 $90.67 45 399
Apr 26, 2024 $89.31 $89.86 $89.02 $89.60 26 287
Apr 25, 2024 $89.35 $90.24 $88.88 $90.16 30 221
Apr 24, 2024 $91.91 $91.91 $89.68 $90.10 30 771
Apr 23, 2024 $90.00 $90.73 $90.00 $90.71 34 431
Apr 22, 2024 $85.96 $90.00 $85.96 $89.17 54 046
Apr 19, 2024 $85.98 $87.10 $85.98 $86.82 52 169
Apr 18, 2024 $86.80 $88.21 $86.80 $86.92 59 529
Apr 17, 2024 $87.88 $88.25 $87.43 $87.96 44 471
Apr 16, 2024 $87.85 $88.29 $87.30 $87.83 47 941
Apr 15, 2024 $91.68 $91.68 $89.37 $89.50 43 989
Apr 12, 2024 $92.18 $92.18 $90.83 $91.51 17 532
Apr 11, 2024 $92.18 $92.18 $90.56 $91.49 24 763
Apr 10, 2024 $91.79 $94.33 $91.75 $92.00 19 386
Apr 09, 2024 $93.11 $93.21 $92.39 $92.91 23 471
Apr 08, 2024 $91.32 $93.09 $91.32 $93.08 26 300
Apr 05, 2024 $92.55 $92.55 $91.90 $92.29 33 301
Apr 04, 2024 $93.33 $93.71 $92.40 $92.57 31 062
Apr 03, 2024 $93.06 $93.06 $92.00 $92.72 45 572
Click to get the best stock tips daily for free!

About CSL Ltd.

CSL Ltd. CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants for the treatment of immunodeficiency, bleeding disorders, hereditary angioede... CSLLY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT